Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| BRAF | P15056 | Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1) | Cancer-related genesDisease related genesEnzymes | CardiomyopathyDeafnessEctodermal dysplasia | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.40 | |||
| BST1 | Q10588 | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 (EC 3.2.2.6) (ADP-ribosyl cyclase 2) (Bone marrow stromal cell antigen 1) (BST-1) (Cyclic ADP-ribose hydrolase 2) (cADPR hydrolase 2) (CD antigen CD157) | CD markersEnzymesFDA approved drug targets | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.40 | ||||
| BT2A1 | Q7KYR7 | Butyrophilin subfamily 2 member A1 | Predicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.40 | |||
| BT3A3 | O00478 | Butyrophilin subfamily 3 member A3 | Predicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.40 | |||
| BTBDI | B2RXH4 | BTB/POZ domain-containing protein 18 | Predicted intracellular proteins | Other mediation | 1 | 0.40 | ||||
| BTLA | Q7Z6A9 | B- and T-lymphocyte attenuator (B- and T-lymphocyte-associated protein) (CD antigen CD272) | CD markersPredicted membrane proteinsPredicted secreted proteins | 1 | Lupus erythematosusSjogren syndromeSolid tumour/cancer | Clinical-translation mediationImmune mediation | 1 | 0.40 | ||
| C1QBP | Q07021 | Complement component 1 Q subcomponent-binding protein, mitochondrial (ASF/SF2-associated protein p32) (Glycoprotein gC1qBP) (C1qBP) (Hyaluronan-binding protein 1) (Mitochondrial matrix protein p32) (gC1q-R protein) (p33) (SF2AP32) | Cancer-related genesDisease related genesHuman disease related genes | Primary mitochondrial disease | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 1 | 0.40 | |||
| CA054 | Q8WWF1 | Uncharacterized protein C1orf54 | Predicted secreted proteins | Other mediation | 1 | 0.40 | ||||
| CA074 | Q96LT6 | UPF0739 protein C1orf74 | Predicted intracellular proteins | Other mediation | 1 | 0.40 | ||||
| CANB1 | P63098 | Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1) | FDA approved drug targetsPredicted intracellular proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.40 |